These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 6438758)

  • 1. Genetic characterization and cloning of the toxic shock syndrome exotoxin.
    Kreiswirth BN; O'Reilly M; Novick RP
    Surv Synth Pathol Res; 1984; 3(1):73-82. PubMed ID: 6438758
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic studies on Staphylococcal strains from patients with toxic shock syndrome.
    Kreiswirth BN; Novick RP; Schlievert PM; Bergdoll M
    Ann Intern Med; 1982 Jun; 96(6 Pt 2):974-7. PubMed ID: 6212007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of prooxidants on viability of experimental animals and chemiluminescence of whole blood cells exposed to the Staphylococcus aureus toxic shock exotoxin in vivo].
    Shepelev AP; Antipov AIu; Poliakov VM
    Biull Eksp Biol Med; 1995 Sep; 120(9):258-9. PubMed ID: 8593331
    [No Abstract]   [Full Text] [Related]  

  • 4. Biological properties of toxic shock syndrome exotoxin.
    Schlievert PM
    Surv Synth Pathol Res; 1984; 3(1):54-62. PubMed ID: 6505480
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute systemic immune activation following vaginal exposure to staphylococcal enterotoxin B--implications for menstrual shock.
    Rajagopalan G; Smart MK; Murali N; Patel R; David CS
    J Reprod Immunol; 2007 Feb; 73(1):51-9. PubMed ID: 17070600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of superantigenic toxin Vbeta T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock.
    Ferry T; Thomas D; Perpoint T; Lina G; Monneret G; Mohammedi I; Chidiac C; Peyramond D; Vandenesch F; Etienne J
    Clin Microbiol Infect; 2008 Jun; 14(6):546-54. PubMed ID: 18373692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the staphylococcal causation of toxic shock syndrome.
    Altemeier WA; Lewis S; Schlievert PM; Bjornson HS
    Surg Gynecol Obstet; 1981 Oct; 153(4):481-5. PubMed ID: 6456561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic sinusitis with nasal polyps: staphylococcal exotoxin immunoglobulin E and cellular inflammation.
    Conley DB; Tripathi A; Ditto AM; Reid K; Grammer LC; Kern RC
    Am J Rhinol; 2004; 18(5):273-8. PubMed ID: 15586797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-partum toxic shock syndrome due to an unexpected source.
    Sam IC; Ng PH
    J Obstet Gynaecol; 2002 Sep; 22(5):556. PubMed ID: 12521433
    [No Abstract]   [Full Text] [Related]  

  • 10. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage.
    Kreiswirth BN; Löfdahl S; Betley MJ; O'Reilly M; Schlievert PM; Bergdoll MS; Novick RP
    Nature; 1983 Oct 20-26; 305(5936):709-12. PubMed ID: 6226876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome.
    De Boer ML; Kum WW; Chow AW
    Can J Microbiol; 1999 Mar; 45(3):250-6. PubMed ID: 10408098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between urticaria-like toxic allergic exanthema and infection by toxin-producing Staphylococcus strains in infants].
    Tóth P
    Orv Hetil; 1994 Dec; 135(49):2701-3. PubMed ID: 7991243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contribution to the problem of toxic shock syndrome].
    Jakab L
    Orv Hetil; 2003 Jun; 144(25):1267-8; author reply 1268. PubMed ID: 12901183
    [No Abstract]   [Full Text] [Related]  

  • 14. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.
    Darenberg J; Söderquist B; Normark BH; Norrby-Teglund A
    Clin Infect Dis; 2004 Mar; 38(6):836-42. PubMed ID: 14999628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcal cutaneous infections: invasion, evasion and aggression.
    Iwatsuki K; Yamasaki O; Morizane S; Oono T
    J Dermatol Sci; 2006 Jun; 42(3):203-14. PubMed ID: 16679003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: a lethal cause of pneumonia in an adult immunocompetent patient.
    Magira EE; Zervakis D; Routsi C; Kontogiorgi M; Roussos C; Nanas S; Mentzelopoulos S
    Scand J Infect Dis; 2007; 39(5):466-9. PubMed ID: 17464874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Will therapeutic peptides be kryptonite for superantigens?
    Schlievert PM
    Nat Med; 2000 Apr; 6(4):378-9. PubMed ID: 10742138
    [No Abstract]   [Full Text] [Related]  

  • 18. TREM-1 amplifies inflammation and is a crucial mediator of septic shock.
    Bouchon A; Facchetti F; Weigand MA; Colonna M
    Nature; 2001 Apr; 410(6832):1103-7. PubMed ID: 11323674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
    Arad G; Levy R; Hillman D; Kaempfer R
    Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxic shock syndrome due to group A streptococcal pharyngitis and bacteremia in an adult.
    Vucicevic Z; Bencic IJ; Kruslin B; Degoricija V
    J Microbiol Immunol Infect; 2008 Aug; 41(4):351-4. PubMed ID: 18787744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.